ZIYOND focuses on facial skin diseases, superficial fungal infections, onychomycosis, immune-inflammatory skin diseases, pigmentary disorders and scalp and hair diseases. The company has developed a product portfolio covering brands such as Luofu®, Lifu®, Jinniuer® and ZRVIVE®. Its products are available on major online healthcare platforms including Alibaba Health and JD Health and have received honors such as AAA-Level Well-Known Trademark Brand and 2023 Excellent Brand.
The company has established a CNAS-accredited laboratory, a BSL-2 laboratory, a National Postdoctoral Research Workstation and several provincial R&D platforms. It has also built partnerships with the Jiangsu Industrial Technology Research Institute, China Pharmaceutical University, Jiangnan University and other institutions to support innovation in topical dermatological formulations and cosmetic ingredients.
Looking ahead, ZIYOND will continue to promote both technological innovation and marketing innovation. The company will expand its product portfolio affecting the entire body, extend its business from pharmaceuticals to cosmeceutical products and develop its market from China to international markets. ZIYOND aims to become a leader in skin health.
